RxDoctor Payments Data

Donald Hohman, MD

Adult Reconstructive Orthopaedic Surgery · Dallas, TXNPI 1801235833

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $347,352 of the $537,406 with a category attached, or 64.6%. It is spread thinly across 44 manufacturers, the largest accounting for just 19.4%. Reporting peaked in 2019 at $145,026 and has fallen 64.7% since, to $51,266 in 2025. Among adult reconstructive orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$537,406in general payments, 2019–2025

Across 410 payments — averaging $1310.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanara Medtech Inc.$104K
  • Limacorporate S.p.a.$86K
  • Advanced Orthopaedic Solutions, Inc.$79K
  • Arthrex$57K
  • Encore Medical, LP$43K
  • Kyocera Medical Technologies, Inc.$30K
  • plus $138K from 38 others
$501,810in research payments, 2019–2025

Across 18 payments — averaging $27,878 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kyocera Medical Technologies, Inc.$488K
  • Omnilife Science, Inc$14K

What the payments were for

  • Royalty or licence$19,4374%
  • Consulting fees$347,35265%
  • Speaking & faculty fees$88,67517%
  • Travel & lodging$66,73812%
  • Food & beverage$12,6002%
  • Gifts$1140%
  • Other$2,4900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$537,406 in reported general payments places this provider in the 95th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$429,361
Medicare patients
600
Services billed
4,541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib74$1,806
Gabapentin93$490
Oxycodone Hcl72$414
Tramadol Hcl73$316
Ondansetron Hcl85$255
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$116
Amoxicillin47$71
Ondansetron OdtOndansetron11$58

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →